Copyright Reports & Markets. All rights reserved.

Global Mammalian CDMO Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Mammalian CDMO Service by Type
    • 1.3.1 Overview: Global Mammalian CDMO Service Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Mammalian CDMO Service Consumption Value Market Share by Type in 2023
    • 1.3.3 Cell Line Development
    • 1.3.4 Genomic Analysis
    • 1.3.5 Process Development
    • 1.3.6 Analytical Services
    • 1.3.7 Formulation Development
    • 1.3.8 Manufacturing
    • 1.3.9 Others
  • 1.4 Global Mammalian CDMO Service Market by Application
    • 1.4.1 Overview: Global Mammalian CDMO Service Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Contract Research Organizations (CROs)
    • 1.4.3 Pharmaceutical
    • 1.4.4 Biotechnology Companies
    • 1.4.5 Government Agencies
    • 1.4.6 Others
  • 1.5 Global Mammalian CDMO Service Market Size & Forecast
  • 1.6 Global Mammalian CDMO Service Market Size and Forecast by Region
    • 1.6.1 Global Mammalian CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Mammalian CDMO Service Market Size by Region, (2019-2030)
    • 1.6.3 North America Mammalian CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Mammalian CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Mammalian CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.6 South America Mammalian CDMO Service Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Mammalian CDMO Service Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Cytovance Biologics
    • 2.1.1 Cytovance Biologics Details
    • 2.1.2 Cytovance Biologics Major Business
    • 2.1.3 Cytovance Biologics Mammalian CDMO Service Product and Solutions
    • 2.1.4 Cytovance Biologics Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Cytovance Biologics Recent Developments and Future Plans
  • 2.2 3P Bio
    • 2.2.1 3P Bio Details
    • 2.2.2 3P Bio Major Business
    • 2.2.3 3P Bio Mammalian CDMO Service Product and Solutions
    • 2.2.4 3P Bio Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 3P Bio Recent Developments and Future Plans
  • 2.3 AGC Biologics
    • 2.3.1 AGC Biologics Details
    • 2.3.2 AGC Biologics Major Business
    • 2.3.3 AGC Biologics Mammalian CDMO Service Product and Solutions
    • 2.3.4 AGC Biologics Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AGC Biologics Recent Developments and Future Plans
  • 2.4 KBI Biopharma
    • 2.4.1 KBI Biopharma Details
    • 2.4.2 KBI Biopharma Major Business
    • 2.4.3 KBI Biopharma Mammalian CDMO Service Product and Solutions
    • 2.4.4 KBI Biopharma Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 KBI Biopharma Recent Developments and Future Plans
  • 2.5 GTP Bioways
    • 2.5.1 GTP Bioways Details
    • 2.5.2 GTP Bioways Major Business
    • 2.5.3 GTP Bioways Mammalian CDMO Service Product and Solutions
    • 2.5.4 GTP Bioways Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 GTP Bioways Recent Developments and Future Plans
  • 2.6 Tanvex CDMO
    • 2.6.1 Tanvex CDMO Details
    • 2.6.2 Tanvex CDMO Major Business
    • 2.6.3 Tanvex CDMO Mammalian CDMO Service Product and Solutions
    • 2.6.4 Tanvex CDMO Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Tanvex CDMO Recent Developments and Future Plans
  • 2.7 Samsung Biologics
    • 2.7.1 Samsung Biologics Details
    • 2.7.2 Samsung Biologics Major Business
    • 2.7.3 Samsung Biologics Mammalian CDMO Service Product and Solutions
    • 2.7.4 Samsung Biologics Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Samsung Biologics Recent Developments and Future Plans
  • 2.8 WuXi Biologics
    • 2.8.1 WuXi Biologics Details
    • 2.8.2 WuXi Biologics Major Business
    • 2.8.3 WuXi Biologics Mammalian CDMO Service Product and Solutions
    • 2.8.4 WuXi Biologics Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 WuXi Biologics Recent Developments and Future Plans
  • 2.9 PlantForm Corporation
    • 2.9.1 PlantForm Corporation Details
    • 2.9.2 PlantForm Corporation Major Business
    • 2.9.3 PlantForm Corporation Mammalian CDMO Service Product and Solutions
    • 2.9.4 PlantForm Corporation Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 PlantForm Corporation Recent Developments and Future Plans
  • 2.10 Gedeon Richter
    • 2.10.1 Gedeon Richter Details
    • 2.10.2 Gedeon Richter Major Business
    • 2.10.3 Gedeon Richter Mammalian CDMO Service Product and Solutions
    • 2.10.4 Gedeon Richter Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Gedeon Richter Recent Developments and Future Plans
  • 2.11 Lonza
    • 2.11.1 Lonza Details
    • 2.11.2 Lonza Major Business
    • 2.11.3 Lonza Mammalian CDMO Service Product and Solutions
    • 2.11.4 Lonza Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Lonza Recent Developments and Future Plans
  • 2.12 Novartis
    • 2.12.1 Novartis Details
    • 2.12.2 Novartis Major Business
    • 2.12.3 Novartis Mammalian CDMO Service Product and Solutions
    • 2.12.4 Novartis Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Novartis Recent Developments and Future Plans
  • 2.13 Rentschler Biopharma SE
    • 2.13.1 Rentschler Biopharma SE Details
    • 2.13.2 Rentschler Biopharma SE Major Business
    • 2.13.3 Rentschler Biopharma SE Mammalian CDMO Service Product and Solutions
    • 2.13.4 Rentschler Biopharma SE Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Rentschler Biopharma SE Recent Developments and Future Plans
  • 2.14 Northway Biotech
    • 2.14.1 Northway Biotech Details
    • 2.14.2 Northway Biotech Major Business
    • 2.14.3 Northway Biotech Mammalian CDMO Service Product and Solutions
    • 2.14.4 Northway Biotech Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Northway Biotech Recent Developments and Future Plans
  • 2.15 Boehringer Ingelheim
    • 2.15.1 Boehringer Ingelheim Details
    • 2.15.2 Boehringer Ingelheim Major Business
    • 2.15.3 Boehringer Ingelheim Mammalian CDMO Service Product and Solutions
    • 2.15.4 Boehringer Ingelheim Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.16 Cambrex
    • 2.16.1 Cambrex Details
    • 2.16.2 Cambrex Major Business
    • 2.16.3 Cambrex Mammalian CDMO Service Product and Solutions
    • 2.16.4 Cambrex Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Cambrex Recent Developments and Future Plans
  • 2.17 FUJIFILM Diosynth Biotechnologies
    • 2.17.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.17.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.17.3 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Product and Solutions
    • 2.17.4 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.18 GBI
    • 2.18.1 GBI Details
    • 2.18.2 GBI Major Business
    • 2.18.3 GBI Mammalian CDMO Service Product and Solutions
    • 2.18.4 GBI Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 GBI Recent Developments and Future Plans
  • 2.19 Scorpius BioManufacturing
    • 2.19.1 Scorpius BioManufacturing Details
    • 2.19.2 Scorpius BioManufacturing Major Business
    • 2.19.3 Scorpius BioManufacturing Mammalian CDMO Service Product and Solutions
    • 2.19.4 Scorpius BioManufacturing Mammalian CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Scorpius BioManufacturing Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Mammalian CDMO Service Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Mammalian CDMO Service by Company Revenue
    • 3.2.2 Top 3 Mammalian CDMO Service Players Market Share in 2023
    • 3.2.3 Top 6 Mammalian CDMO Service Players Market Share in 2023
  • 3.3 Mammalian CDMO Service Market: Overall Company Footprint Analysis
    • 3.3.1 Mammalian CDMO Service Market: Region Footprint
    • 3.3.2 Mammalian CDMO Service Market: Company Product Type Footprint
    • 3.3.3 Mammalian CDMO Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Mammalian CDMO Service Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Mammalian CDMO Service Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Mammalian CDMO Service Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Mammalian CDMO Service Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Mammalian CDMO Service Consumption Value by Type (2019-2030)
  • 6.2 North America Mammalian CDMO Service Market Size by Application (2019-2030)
  • 6.3 North America Mammalian CDMO Service Market Size by Country
    • 6.3.1 North America Mammalian CDMO Service Consumption Value by Country (2019-2030)
    • 6.3.2 United States Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Mammalian CDMO Service Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Mammalian CDMO Service Consumption Value by Type (2019-2030)
  • 7.2 Europe Mammalian CDMO Service Consumption Value by Application (2019-2030)
  • 7.3 Europe Mammalian CDMO Service Market Size by Country
    • 7.3.1 Europe Mammalian CDMO Service Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.3 France Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Mammalian CDMO Service Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Mammalian CDMO Service Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Mammalian CDMO Service Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Mammalian CDMO Service Market Size by Region
    • 8.3.1 Asia-Pacific Mammalian CDMO Service Consumption Value by Region (2019-2030)
    • 8.3.2 China Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.5 India Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Mammalian CDMO Service Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Mammalian CDMO Service Consumption Value by Type (2019-2030)
  • 9.2 South America Mammalian CDMO Service Consumption Value by Application (2019-2030)
  • 9.3 South America Mammalian CDMO Service Market Size by Country
    • 9.3.1 South America Mammalian CDMO Service Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Mammalian CDMO Service Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Mammalian CDMO Service Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Mammalian CDMO Service Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Mammalian CDMO Service Market Size by Country
    • 10.3.1 Middle East & Africa Mammalian CDMO Service Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Mammalian CDMO Service Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Mammalian CDMO Service Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Mammalian CDMO Service Market Drivers
  • 11.2 Mammalian CDMO Service Market Restraints
  • 11.3 Mammalian CDMO Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Mammalian CDMO Service Industry Chain
  • 12.2 Mammalian CDMO Service Upstream Analysis
  • 12.3 Mammalian CDMO Service Midstream Analysis
  • 12.4 Mammalian CDMO Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Mammalian CDMO Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Mammalian CDMO Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Mammalian CDMO Service market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Mammalian CDMO Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Mammalian CDMO Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Mammalian CDMO Service market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Mammalian CDMO Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Mammalian CDMO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Mammalian CDMO Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Mammalian CDMO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cell Line Development
    Genomic Analysis
    Process Development
    Analytical Services
    Formulation Development
    Manufacturing
    Others
    Market segment by Application
    Contract Research Organizations (CROs)
    Pharmaceutical
    Biotechnology Companies
    Government Agencies
    Others
    Market segment by players, this report covers
    Cytovance Biologics
    3P Bio
    AGC Biologics
    KBI Biopharma
    GTP Bioways
    Tanvex CDMO
    Samsung Biologics
    WuXi Biologics
    PlantForm Corporation
    Gedeon Richter
    Lonza
    Novartis
    Rentschler Biopharma SE
    Northway Biotech
    Boehringer Ingelheim
    Cambrex
    FUJIFILM Diosynth Biotechnologies
    GBI
    Scorpius BioManufacturing
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Mammalian CDMO Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Mammalian CDMO Service, with revenue, gross margin, and global market share of Mammalian CDMO Service from 2019 to 2024.
    Chapter 3, the Mammalian CDMO Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Mammalian CDMO Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Mammalian CDMO Service.
    Chapter 13, to describe Mammalian CDMO Service research findings and conclusion.

    Buy now